Medicine guide

Sugammadex Mylan

·

  • Prescription status not stated
  • Everything that fits nowhere else, such as contrast media
Active substance
Sugammadex
Made by
Mylan Pharmaceuticals Limited

Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.

What it is for

Some medicines reduce the effect of Sugammadex Mylan It is especially important that you tell your anaesthetist if you have recently taken:

  • What Sugammadex Mylan is Sugammadex Mylan contains the active substance sugammadex. Sugammadex Mylan is considered to be a selective relaxant binding agent since it only works with specific muscle relaxants, rocuronium bromide or vecuronium bromide.
  • What Sugammadex Mylan is used for When you have some types of operations, your muscles must be completely relaxed. This makes it easier for the surgeon to do the operation. For this, the general anaesthetic you are given includes medicines to make your muscles relax. These are called muscle relaxants, and examples include rocuronium bromide and vecuronium bromide. Because these medicines also make your breathing muscles relax, you need help to breathe (artificial ventilation) during and after your operation until you can breathe on your own again.
  • Sugammadex Mylan is used to speed up the recovery of your muscles after an operation to allow you to breathe on your own again earlier. It does this by combining with the rocuronium bromide or vecuronium bromide in your body. It can be used in adults whenever rocuronium bromide or vecuronium bromide is used. It can be used in newborn babies, infants, toddlers, children and adolescents (birth to 17 years) when rocuronium bromide is used.
  • 2. What you need to know before Sugammadex Mylan is given You should not be given Sugammadex Mylan
  • • if you are allergic to sugammadex or any of the other ingredients of this medicine (listed in section 6).
  • Tell your anaesthetist if this applies to you.
  • Warnings and precautions Talk to your anaesthetist before Sugammadex Mylan is given
  • • if you have kidney disease or had in the past. This is important as sugammadex is removed from your body by the kidneys.
  • • if you have liver disease or have had it in the past.
  • • if you have fluid retention (oedema).
  • • if you have diseases which are known to give an increased risk of bleeding (disturbances of blood clotting) or anticoagulation medication.
  • Other medicines and Sugammadex Mylan Tell your anaesthetist if you are taking, have recently taken or might take any other medicines.
  • Sugammadex Mylan may affect other medicines or be affected by them.
  • • toremifene (used to treat breast cancer).
  • • fusidic acid (an antibiotic).
  • Sugammadex Mylan can affect hormonal contraceptives Sugammadex Mylan can make hormonal contraceptives - including the ‘Pill’, vaginal ring, implants or a hormonal IntraUterine System (IUS) - less effective because it reduces how much you get of the progestogen hormone. The amount of progestogen lost by using Sugammadex Mylan is about the same as missing one oral contraceptive Pill.
  • • If you are taking the Pill on the same day as Sugammadex Mylan is given to you, follow the instructions for a missed dose in the Pill’s package leaflet.
  • • If you are using other hormonal contraceptives (for example a vaginal ring, implant or IUS)
  • you should use an additional non-hormonal contraceptive method (such as a condom) for the next 7 days and follow the advice in the package leaflet.
  • Effects on blood tests In general, Sugammadex Mylan does not have an effect on laboratory tests. However, it may affect the results of a blood test for a hormone called progesterone. Talk to your doctor if your progesterone levels need to be tested on the same day you receive Sugammadex Mylan Pregnancy and breast-feeding Tell your anaesthetist if you are pregnant or might be pregnant or if you are breast-feeding.
  • You may still be given Sugammadex Mylan, but you need to discuss it first.
  • It is not known whether sugammadex can pass into breast milk. Your anaesthetist will help you decide whether to stop breast-feeding, or whether to abstain from sugammadex therapy, considering the benefit of breast-feeding to the baby and the benefit of Sugamadex Mylan to the mother.
  • Driving and using machines Sugammadex Mylan has no known influence on your ability to drive and use machines.
  • Sugammadex Mylan contains sodium This medicine contains up to 9.2 mg sodium (main component of cooking / table salt) in each mL.
  • This is equivalent to 0.5 % of the recommended maximum daily dietary intake of sodium for an adult.

From the package leaflet in EMA’s product information, p. 28–29 · 2026-06-12

How to take it

These directions are for this exact strength and form. Another one is different.

  • Sugammadex Mylan will be given to you by your anaesthetist, or under the care of your anaesthetist.
  • The dose Your anaesthetist will work out the dose of Sugammadex Mylan you need based on:
  • your weight
  • how much the muscle relaxant medicine is still affecting you.
  • The usual dose is 2-4 mg per kg body weight for patients of any age. A dose of 16 mg/kg can be used in adults if urgent recovery from muscle relaxation is needed.
  • How Sugammadex Mylan is given Sugammadex Mylan will be given to you by your anaesthetist. It is given as a single injection through an intravenous line.
  • If more Sugammadex Mylan is given to you than recommended As your anaesthetist will be monitoring your condition carefully, it is unlikely that you will be given too much Sugammadex Mylan. But even if this happens, it is unlikely to cause any problems.
  • If you have any further questions on the use of this medicine, ask your anaesthetist or other doctor.

From the package leaflet in EMA’s product information, p. 29–30.

Side effects

  • Like all medicines, this medicine can cause side effects, although not everybody gets them. If these side effects occur while you are under anaesthesia, they will be seen and treated by your anaesthetist.
  • Common side effects (may affect up to 1 in 10 people)
  • Cough
  • Airway difficulties that may include coughing or moving as if you are waking or taking a breath
  • Light anaesthesia - you may start to come out of deep sleep, so need more anaesthesia. This might cause you to move or cough at the end of the operation
  • Complications during your procedure such as changes in heart rate, coughing or moving
  • Decreased blood pressure due to the surgical procedure Uncommon side effects (may affect up to 1 in 100 people)
  • Shortness of breath due to muscle cramps of the airways (bronchospasm) occurred in patients with a history of lung problems
  • Allergic (drug hypersensitivity) reactions - such as a rash, red skin, swelling of your tongue and/or throat, shortness of breath, changes in blood pressure or heart rate, sometimes resulting in a serious decrease of blood pressure. Severe allergic or allergic-like reactions can be life threatening.
  • Allergic reactions were reported more commonly in healthy, conscious volunteers.
  • Return of muscle relaxation after the operation Frequency not known
  • Severe slowing of the heart and slowing of the heart up to cardiac arrest may occur when Sugammadex Mylan is administered.
  • Reporting of side effects If you get any side effects, talk to your anaesthetist or other doctor This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.

From the package leaflet in EMA’s product information, p. 30.

How to store it

  • Storage will be handled by healthcare professionals.
  • Keep this medicine out of the sight and reach of children.
  • Do not use this medicine after the expiry date which is stated on the carton and on the label after ‘EXP’. The expiry date refers to the last day of that month.
  • After first opening and dilution, store at 2 °C to 8 °C and use within 24 hours.
  • Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

From the package leaflet in EMA’s product information, p. 30.

Same active substance, strength and form in other countries

Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.

Medicine passport: one printable page to show a pharmacist abroad

United StatesNo exact match for this strength and form

BulgariaNo exact match for this strength and form

SpainNo exact match for this strength and form

CanadaNo exact match for this strength and form

NetherlandsNo exact match for this strength and form

SwitzerlandNo exact match for this strength and form

Details

Made byMylan Pharmaceuticals Limited
Active substanceSugammadex
Used inEverything that fits nowhere else, such as contrast media
ClassificationV03AB35 · Everything that fits nowhere else, such as contrast media
GenericYes — a generic medicine, according to the register
Authorised on2021-11-15
Last updated by the regulator2026-06-12
EMA product numberEMEA/H/C/005403

Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician

Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).

Same active substance

These contain the same substance. That does not mean one can replace another — ask a pharmacist.